24/7 Patient Assistance: 760-405-8205

Henry Gerad , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Pericardial Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Henry Gerad is a medical oncologist from Lima ,Ohio and he works at several hospitals in the area, such as Licking Memorial Hospital and Lima Memorial Health System. He did his Medical Schooling from Icahn School of Medicine at Mount Sinai and Residency in Internal Medicine from Drexel University - Hahnemann University Hospital. The doctor is certified in Medical Oncology & Internal Medicine from American Board of Internal Medicine and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Icahn School of Medicine at Mount Sinai

    Medical School

    dept_icon

    Drexel University - Hahnemann University Hospital

    Residency

    dept_icon

    National Cancer Institute

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Lima Memorial Health System

    Languages: English/Spanish

    +1 419-228-3335

    1001 Bellefontaine Ave

    Lima, OH 45804

    Read More
  • Publications & Memberships

    Dr. Henry Gerad has contributed to 3 publications.

    Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.

    Gerad, H., van Echo, D. A., Whitacre, M., Ashman, M., Helrich, M., Foy, J., Ostrow, S., Wiernik, P. H., Aisner, J.; Cancer. 1984 Jun 15.

    See more >>

    Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.

    Gordon, M. S., Young, M. L., Tallman, M. S., Cripe, L. D., Bennett, J. M., Paietta, E., Longo, W., Gerad, H., Mazza, J., Rowe, J. M.; Leuk Res. 2000 Oct.

    See more >>

    Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia.

    Gerad, H., Van Echo, D. A., Donehower, M., Pocelinko, R., Wiernik, P. H.; Cancer Treat Rep. 1984 Mar.

    See more >>